aclacinomycin has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayssas, M; de Vassal, F; Delgado, M; Gil, MA; Gouveia, J; Hayat, M; Jasmin, C; Machover, D; Mathé, G; Misset, JL; Ribaud, P; Schwarzenberg, L | 1 |
Hirano, S; Hori, S; Inui, T; Ishizuka, M; Oki, T; Shirai, M; Takeuchi, T; Tsukagoshi, S; Umezawa, H | 1 |
Chiba, S; Kikuchi, M; Misago, M; Mori, N; Nagata, K; Nakata, K; Ogawa, R; Sato, T; Tsukada, J; Wake, A | 1 |
Kanai, M; Kanno, M; Kobayashi, K; Kondo, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okafuji, K; Yoshida, T | 1 |
4 other study(ies) available for aclacinomycin and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Child; Drug Evaluation; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Naphthacenes | 1980 |
Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Topics: Aclarubicin; Animals; Anthraquinones; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Doxorubicin; Electrocardiography; Glycosides; Heart; Leukemia L1210; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Mesocricetus; Mice; Mice, Inbred Strains; Sarcoma 180; Sarcoma, Experimental; Streptomyces | 1977 |
[Modified CHOP therapy in patients with non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1991 |
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Time Factors | 1989 |